Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,365 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00526734 | High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma | unknown | Phase 2 | 100 | Erasme University HospitalOTHER | 2 | Aug 12, 2013 | clinicaltrials |
| NCT00064051 | 3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer | completed | Phase 2 | — | Vion PharmaceuticalsINDUSTRY | 3 | Aug 2, 2013 | clinicaltrials |
| NCT00463515 | Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation for Non-resectable Stage III NSCLC(CHER@NOS) | completed | Phase 2 | 77 | University Hospital, AntwerpOTHER | 1 | Jul 12, 2013 | clinicaltrials |
| NCT00992186 | A Study of the Safety and Efficacy of Single-agent Carlumab (an Anti-Chemokine Ligand 2 [CCL2]) in Participants With Metastatic Castrate-Resistant Prostate Cancer | completed | Phase 2 | 46 | Centocor Research & Development, Inc.INDUSTRY | 4 | Jun 24, 2013 | clinicaltrials |
| NCT00530764 | A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy.(SPRAY) | completed | Phase 2 | 360 | GW Pharmaceuticals LtdINDUSTRY | 16 | Jun 20, 2013 | clinicaltrials |
| NCT00537381 | An Efficacy and Safety Study of Intetumumab (CNTO 95) in Participants With Metastatic Hormone Refractory Prostate Cancer | completed | Phase 2 | 131 | Centocor, Inc.INDUSTRY | 10 | Jun 20, 2013 | clinicaltrials |
| NCT01537536 | Trial of Neoadjuvant EndoTAG-1 in Combination With Paclitaxel in HER2-negative Breast Cancer(EndoTAG-1) | completed | Phase 2 | 18 | Jules Bordet InstituteOTHER | 1 | Jun 17, 2013 | clinicaltrials |
| NCT00014274 | Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium | completed | Phase 2 / Phase 3 | 238 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Jun 12, 2013 | clinicaltrials |
| NCT01032291 | A Study to Assess the Efficacy and Safety of Lenalidomide in Combination With Cetuximab in Pre-treated Patients With KRAS Mutant Colorectal Cancer | terminated | Phase 2 | 51 | Celgene CorporationINDUSTRY | 6 | May 21, 2013 | clinicaltrials |
| NCT00785122 | IMA910 Plus GM-CSF With Low-dose Cyclophosphamide Pre-treatment in Advanced Colorectal Carcinoma Patients Following a Successful 12 Week First-line Treatment With Oxaliplatin-based Chemotherapy (IMA910-101)(IMA910-101) | completed | Phase 1 / Phase 2 | 92 | Immatics Biotechnologies GmbHINDUSTRY | 9 | May 16, 2013 | clinicaltrials |
| NCT00707889 | Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer | completed | Phase 2 | 159 | AbbVie (prior sponsor, Abbott)INDUSTRY | 14 | May 15, 2013 | clinicaltrials |
| NCT00363051 | Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy | completed | Phase 2 | 160 | Novartis PharmaceuticalsINDUSTRY | 11 | May 10, 2013 | clinicaltrials |
| NCT00107016 | Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal Women | completed | Phase 2 | 267 | Novartis PharmaceuticalsINDUSTRY | 10 | Mar 4, 2013 | clinicaltrials |
| NCT00988741 | Trial of ARQ 197 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Who Have Failed One Prior Systemic Therapy | completed | Phase 2 | 107 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 5 | Feb 28, 2013 | clinicaltrials |
| NCT00959946 | Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 32 | PfizerINDUSTRY | 6 | Feb 22, 2013 | clinicaltrials |
| NCT01303328 | Safety and Efficacy Study of Antiviral Local Application to Treat High Grade Cervical Intraepithelial Lesions (CIN2/3)(Colvir-PhaseII) | completed | Phase 2 | 200 | Mithra PharmaceuticalsINDUSTRY | 1 | Feb 18, 2013 | clinicaltrials |
| NCT00464633 | Alvocidib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From Chronic Lymphocytic Leukemia (CLL) | completed | Phase 2 | 165 | SanofiINDUSTRY | 9 | Feb 12, 2013 | clinicaltrials |
| NCT00558103 | Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer | completed | Phase 2 | 163 | GlaxoSmithKlineINDUSTRY | 28 | Feb 4, 2013 | clinicaltrials |
| NCT01138748 | Prediction of the Effectiveness of Hypofractionated Radiation Therapy in Early Stage Lung Cancer by Bio-imaging and Biomarkers(PEARL-2) | terminated | Phase 2 | 5 | University Hospital, GhentOTHER | 1 | Feb 4, 2013 | clinicaltrials |
| NCT00050141 | Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer | completed | Phase 2 | 121 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 6 | Feb 1, 2013 | clinicaltrials |
| NCT00635193 | Efficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin) | completed | Phase 1 / Phase 2 | 138 | AbbVie (prior sponsor, Abbott)INDUSTRY | 9 | Jan 18, 2013 | clinicaltrials |
| NCT00090363 | ZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA) | completed | Phase 2 | 447 | AstraZenecaINDUSTRY | 14 | Jan 8, 2013 | clinicaltrials |
| NCT00382720 | Docetaxel and Oxaliplatin in Gastric Cancer | completed | Phase 2 | 275 | SanofiINDUSTRY | 12 | Jan 7, 2013 | clinicaltrials |
| NCT00327444 | Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites | completed | Phase 2 / Phase 3 | 58 | SanofiINDUSTRY | 9 | Jan 1, 2013 | clinicaltrials |
| NCT00714649 | Neoadjuvant Cetuximab in HNSCC Combined With Curative Surgery(CHIRON) | completed | Phase 1 / Phase 2 | 34 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Nov 14, 2012 | clinicaltrials |
| NCT01280318 | Profile of Plasma Growth Factors Before and After Head and Neck Oncological or Non-oncological Surgery(HNSCC) | completed | Phase 1 / Phase 2 | 60 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Nov 14, 2012 | clinicaltrials |
| NCT00793546 | Study Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast Cancer | terminated | Phase 2 | 42 | PfizerINDUSTRY | 11 | Nov 5, 2012 | clinicaltrials |
| NCT00861120 | Panitumumab and Pegylated Liposomal Doxorubicin for Platinum-Resistant Epithelial Ovarian Cancer With KRAS Wild-type(PaLiDo) | completed | Phase 2 | 33 | Vejle HospitalOTHER | 4 | Oct 26, 2012 | clinicaltrials |
| NCT00278889 | Second Line ColoRectal Cancer Therapy in Combination With Combination of FOL- Folinic Acid(Leucovorin), F - Fluorouracil and OX - Oxaliplatin (FOLFOX)(HORIZON I) | completed | Phase 2 | 215 | AstraZenecaINDUSTRY | 9 | Oct 24, 2012 | clinicaltrials |
| NCT01331915 | Safety and Toxicity Study of Vaccination for Advanced Metastatic Melanoma Patients(THERAVAC) | unknown | Phase 1 / Phase 2 | 23 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Oct 10, 2012 | clinicaltrials |
| NCT00003729 | Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic Leukemia | terminated | Phase 2 | 13 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Sep 24, 2012 | clinicaltrials |
| NCT00003731 | Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors | completed | Phase 2 | 39 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Sep 24, 2012 | clinicaltrials |
| NCT00004884 | Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer | completed | Phase 2 | 96 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 8 | Sep 24, 2012 | clinicaltrials |
| NCT00005826 | Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme | completed | Phase 2 | 17 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Sep 24, 2012 | clinicaltrials |
| NCT00006026 | Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract | completed | Phase 2 | 21 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Sep 24, 2012 | clinicaltrials |
| NCT00006230 | Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer | completed | Phase 2 | 51 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Sep 24, 2012 | clinicaltrials |
| NCT00006357 | STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma | completed | Phase 1 / Phase 2 | 91 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Sep 24, 2012 | clinicaltrials |
| NCT00014599 | Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva | completed | Phase 2 | 31 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Sep 24, 2012 | clinicaltrials |
| NCT00017498 | Gemcitabine in Treating Patients With Recurrent or Metastatic Adenoid Cystic Cancer of the Head and Neck | completed | Phase 2 | 21 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Sep 24, 2012 | clinicaltrials |
| NCT00022620 | Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer | completed | Phase 2 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Sep 24, 2012 | clinicaltrials |
| NCT00023842 | BCG With or Without Mitomycin in Treating Patients With Bladder Cancer | completed | Phase 2 | 97 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Sep 24, 2012 | clinicaltrials |
| NCT00025298 | Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx | terminated | Phase 2 | 5 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Sep 24, 2012 | clinicaltrials |
| NCT00027794 | Radical Prostatectomy in Treating Patients With Locally Advanced Prostate Cancer | completed | Phase 2 | 40 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Sep 24, 2012 | clinicaltrials |
| NCT00039351 | Combination Chemotherapy in Treating Older Patients With Non-Hodgkin's Lymphoma | completed | Phase 2 | 32 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Sep 24, 2012 | clinicaltrials |
| NCT00043004 | Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer | terminated | Phase 2 | 119 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 10 | Sep 24, 2012 | clinicaltrials |
| NCT00052312 | Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer | completed | Phase 2 | 141 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 8 | Sep 24, 2012 | clinicaltrials |
| NCT00052754 | Gefitinib in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma | completed | Phase 2 | 48 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 4 | Sep 24, 2012 | clinicaltrials |
| NCT00060385 | Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma | terminated | Phase 2 / Phase 3 | 3 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Sep 24, 2012 | clinicaltrials |
| NCT00064207 | Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer | completed | Phase 2 / Phase 3 | 97 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Sep 24, 2012 | clinicaltrials |
| NCT00066391 | Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer | completed | Phase 2 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Sep 24, 2012 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials